Literature DB >> 24844455

Pathophysiology of neurally-mediated syncope.

C Malamud-Kessler1, E Bruno2, E Chiquete3, H Sentíes-Madrid2, M Campos-Sánchez4.   

Abstract

INTRODUCTION: Neurally-mediated syncope (NMS) is defined as a transient loss of consciousness due to an abrupt and intermittent drop in blood pressure (BP).
OBJECTIVES: This study describes the putative pathophysiological mechanisms giving rise to NMS, the role of baroreflex (BR), and the interaction of its main haemodynamic variables: heart rate (HR) and BP. DEVELOPMENT: Episodic dysregulation affects control over the haemodynamic variables (HR and BP) mediated by baroreflex mechanisms. During active standing, individuals experience a profound transient drop in systolic BP due to the effect of gravity on the column of blood and probably also because of reflex vasodilation. Abnormalities in the BR in NMS could be due to a more profound drop in BP upon standing, or to delayed or incomplete vasoconstriction resulting from inhibited or delayed sympathetic activity.
CONCLUSIONS: Sympathetic hyperactivity is present in patients with NMS at rest and before syncope. During active standing or passive tilting, excessive tachycardia may be followed by bradycardia and profound hypotension. Recovery of systolic BP is delayed or incomplete.
Copyright © 2014 Sociedad Española de Neurología. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Active Standing; Baroreflex; Barorreflejo; Neurally-mediated syncope; Ortostatismo activo; Prueba de inclinación; Síncope neuralmente mediado; Tilt test

Mesh:

Year:  2014        PMID: 24844455     DOI: 10.1016/j.nrl.2014.04.001

Source DB:  PubMed          Journal:  Neurologia        ISSN: 0213-4853            Impact factor:   3.109


  1 in total

1.  Alterations of brain network hubs in reflex syncope: Evidence from a graph theoretical analysis based on DTI.

Authors:  Bong Soo Park; Yoo Jin Lee; Jin-Han Park; Il Hwan Kim; Si Hyung Park; Ho-Joon Lee; Kang Min Park
Journal:  Brain Behav       Date:  2018-05-23       Impact factor: 2.708

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.